Somerset Pharma is pleased to announce the launch of Calcium Gluconate 100mg/mL 50mL and 100mL vials
Somerset Steps Up Once Again
Somerset Pharma, LLC, a leading US-based pharmaceutical company specializing in sterile injectables and ophthalmic products, announces the introduction of Calcium Gluconate 100mg/mL in two sizes, 50mL and 100mL.
The company is the first to launch generic Calcium Gluconate 100mg/mL in 50mL vials. This product approval also received the FDA’s Competitive Generic Therapy (CGT) designation with 180-day exclusivity.
Calcium Gluconate is an essential medicine used in the treatment of acute symptomatic hypocalcemia in pediatric and adult patients.
“We take our role as a partner to healthcare professionals very seriously, and one of the ways in which we can contribute to their efforts is by constantly enhancing and evolving our productportfolio to cater to patient needs,” said Dr. Veerappan Subramanian, Chairman & CEO at Somerset Pharma, LLC. “We are delighted to be able to contribute once again to this effort, with the launch of Calcium Gluconate Injection, which is also Somerset’s first large volume injectable offering.”
Somerset Pharma is pleased to announce the launch of Succinylcholine Chloride Injection in glass vial. Succinylcholine is used as an adjunct to general anesthesia.
Somerset Pharma announces Launch of Succinylcholine Chloride Injection
Somerset, 23rd April 2020 – Somerset Pharma is pleased to announce the launch of Succinylcholine Chloride Injection in a glass vial. Succinylcholine is used as an adjunct to general anesthesia.
Somerset continues to support the healthcare community by launching this critical drug that will be required during these challenging times. It is our goal to meet the demand for such medicine during the COVID-19 pandemic.
Succinylcholine injection is supplied as a clear colorless solution in a concentration of 20mg/ml in 10 ml vials. The company is launching Succinylcholine injection USP in packs of 25s and 10s.
With this product, Somerset now has 22 products aggregating to 51 different presentations in the market with an additional 45 products in the pipeline.
About Somerset Pharma
Somerset Pharma is a New Jersey-based pharmaceutical company specializing in sterile products. Somerset manufactures and markets injectable and ophthalmic drugs for the U.S. marketplace. Somerset is committed to quality and aims to deliver affordable pharmaceuticals to all customers in the marketplace.
For additional information, please visit us at https://somerset.tpv.dev/ or contact us by email at [email protected].
Naloxone 0.4mg/mL injectable vial, generic equivalent to Narcan®, is launched by Somerset Pharma in the following fill volumes: Naloxone 0.4mg per 1mL Naloxone 4mg per 10mL
Tobramycin 0.3% 3 mL ophthalmic dropper, generic equivalent to Tobrex®, is launched by Somerset Pharma.
Glycopyrrolate 0.2mg/mL injectable vial, generic equivalent to Robinul®, is launched by Somerset Pharma in four fill volumes.
Glycopyrrolate 0.2mg/mL injectable vial, generic equivalent to Robinul®, is launched by Somerset Pharma in the following fill volumes:
Epinastine 0.05% 5 mL ophthalmic dropper, generic equivalent to Elestat®, is launched by Somerset Pharma.
Olopatadine 0.1% 5 mL ophthalmic dropper, generic equivalent to Patanol®, is launched by Somerset Pharma.
Cyanocobalamin 1000mcg per 1 mL, generic equivalent to Vibisone®/Vitamin B-12 injectable vial is launched by Somerset Pharma.